Literature DB >> 6466614

Role of the N-terminus in the interaction of pancreatic phospholipase A2 with aggregated substrates. Properties and crystal structure of transaminated phospholipase A2.

B W Dijkstra, K H Kalk, J Drenth, G H de Haas, M R Egmond, A J Slotboom.   

Abstract

A free N-terminal alpha-NH3+ group is absolutely required for full catalytic activity of phospholipase A2 on aggregated substrates. To elucidate how this alpha-NH3+ group triggers catalytic activity, we specifically transaminated this group in various pancreatic phospholipases A2. Porcine, porcine iso-, equine, human, ovine, and bovine phospholipases A2 all loose catalytic activity on micellar substrates due to the inability of the transaminated proteins to bind to neutral micellar substrate analogues, as was found for the zymogens. Loss of activity is pseudo first order, the rate constants being different for the enzymes studied. The transaminated phospholipases A2 have an intact active site, as catalytic activities on monomeric substrates are comparable to those of the respective zymogens. The X-ray structure of transaminated bovine phospholipase A2 at 2.1-A resolution shows that the N-terminal region and the sequence 63-72 in this protein are more flexible than in the native enzyme. Also, in this respect, the transaminated enzyme very much resembles the zymogen structure. In good agreement with this, it was found by photochemically induced dynamic nuclear polarization 1H NMR that aromatic resonances of Trp-3 and Tyr-69 are affected by transamination. In addition, fluorescence spectroscopy of the unique Trp-3 in transaminated bovine phospholipase A2 revealed a red shift of the emission maximum indicative of a more polar environment of Trp-3 in the transaminated phospholipase A2 as compared to the enzyme.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6466614     DOI: 10.1021/bi00307a035

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Fluorescence of peptide N-terminal 2-oxoacyl and quinoxaline derivatives.

Authors:  R He; C L Tsou
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

2.  Solution structure of porcine pancreatic phospholipase A2 complexed with micelles and a competitive inhibitor.

Authors:  B van den Berg; M Tessari; R Boelens; R Dijkman; R Kaptein; G H de Haas; H M Verheij
Journal:  J Biomol NMR       Date:  1995-02       Impact factor: 2.835

3.  Structure and function of the catalytic site mutant Asp 99 Asn of phospholipase A2: absence of the conserved structural water.

Authors:  A Kumar; C Sekharudu; B Ramakrishnan; C M Dupureur; H Zhu; M D Tsai; M Sundaralingam
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

4.  Serum pancreatic phospholipase A2 and prophospholipase A2 in acute pancreatitis and after endoscopic retrograde pancreatography.

Authors:  K Yamamoto; Y Shinomura; H Tojo; M Okamoto; S Tarui
Journal:  Gastroenterol Jpn       Date:  1993-10

5.  Distinct sites for myotoxic and membrane-damaging activities in the C-terminal region of a Lys49-phospholipase A2.

Authors:  Lucimara Chioato; Arthur H C De Oliveira; Roberto Ruller; Juliana M Sá; Richard J Ward
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

6.  Role of the N-terminal region of phospholipase A2 subunit of beta 1-bungarotoxin in the toxin-Ca2+ complex-formation.

Authors:  S T Chu; Y H Chen
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

7.  Crystal structure of the Y52F/Y73F double mutant of phospholipase A2: increased hydrophobic interactions of the phenyl groups compensate for the disrupted hydrogen bonds of the tyrosines.

Authors:  C Sekharudu; B Ramakrishnan; B Huang; R T Jiang; C M Dupureur; M D Tsai; M Sundaralingam
Journal:  Protein Sci       Date:  1992-12       Impact factor: 6.725

8.  Solution structure of porcine pancreatic phospholipase A2.

Authors:  B van den Berg; M Tessari; G H de Haas; H M Verheij; R Boelens; R Kaptein
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.